share_log

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Sulzberger Gabrielle

SEC announcement ·  Mar 20 04:30
Summary by Futu AI
Gabrielle Sulzberger, associated with Eli Lilly and Co (LLY), completed a purchase of 13 shares of common stock on March 18, 2024. The transaction was carried out at a price of $762.66 per share, amounting to a total investment of $9,914.58. Following this acquisition, Sulzberger's direct holdings in the company increased to a total of 2,115 shares of common stock.
Gabrielle Sulzberger, associated with Eli Lilly and Co (LLY), completed a purchase of 13 shares of common stock on March 18, 2024. The transaction was carried out at a price of $762.66 per share, amounting to a total investment of $9,914.58. Following this acquisition, Sulzberger's direct holdings in the company increased to a total of 2,115 shares of common stock.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.